Literature DB >> 19353246

An evaluation of a fluorometric method for determining binding parameters of drug-carrier complexes using mathematical models based on total drug concentration.

Boontarika Chanvorachote1, Ubonthip Nimmannit, Walaisiri Muangsiri, Lee Kirsch.   

Abstract

A fluorescence method for determining the mode of binding and estimating binding parameters in a model drug-carrier complex was developed using the lipopeptide antibiotic daptomycin and polyamidoamine (PAMAM) dendrimer. Mathematical simulations of model equations describing fluorescence changes induced by antibiotic-carrier binding in terms of total drug concentration were used to evaluate the sensitivity of parameter variation on binding isotherms for both one- and two-site binding models. Nonlinear regression analysis was used to estimate binding parameters and to identify pH-dependent binding models.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19353246     DOI: 10.1007/s10895-009-0471-1

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  13 in total

Review 1.  Dendrimers in biomedical applications--reflections on the field.

Authors:  Sönke Svenson; Donald A Tomalia
Journal:  Adv Drug Deliv Rev       Date:  2005-11-21       Impact factor: 15.470

Review 2.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

Review 3.  Nanocarriers: promising vehicle for bioactive drugs.

Authors:  Manju Rawat; Deependra Singh; S Saraf; Swarnlata Saraf
Journal:  Biol Pharm Bull       Date:  2006-09       Impact factor: 2.233

4.  A novel two-site binding equation presented in terms of the total ligand concentration.

Authors:  Z X Wang; R F Jiang
Journal:  FEBS Lett       Date:  1996-09-02       Impact factor: 4.124

5.  The lipopeptide antibiotic A21978C has a specific interaction with DMPC only in the presence of calcium ions.

Authors:  J H Lakey; R Maget-Dana; M Ptak
Journal:  Biochim Biophys Acta       Date:  1989-10-02

6.  Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein.

Authors:  D E Epps; T J Raub; V Caiolfa; A Chiari; M Zamai
Journal:  J Pharm Pharmacol       Date:  1999-01       Impact factor: 3.765

7.  Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes.

Authors:  J H Lakey; M Ptak
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

8.  Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin.

Authors:  David Jung; Annett Rozek; Mark Okon; Robert E W Hancock
Journal:  Chem Biol       Date:  2004-07

9.  Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism.

Authors:  N Okabe; N Hashizume
Journal:  Biol Pharm Bull       Date:  1994-01       Impact factor: 2.233

10.  The protein-binding and drug release properties of macromolecular conjugates containing daptomycin and dextran.

Authors:  Walaisiri Muangsiri; Lee E Kirsch
Journal:  Int J Pharm       Date:  2006-03-20       Impact factor: 5.875

View more
  3 in total

1.  Selective fluorescent detection of aspartic acid and glutamic acid employing dansyl hydrazine dextran conjugate.

Authors:  Weerachai Nasomphan; Pramuan Tangboriboonrat; Sutipa Tanapongpipat; Srung Smanmoo
Journal:  J Fluoresc       Date:  2013-08-15       Impact factor: 2.217

2.  Characterizing low affinity epibatidine binding to α4β2 nicotinic acetylcholine receptors with ligand depletion and nonspecific binding.

Authors:  Alexandra M Person; Gregg B Wells
Journal:  BMC Biophys       Date:  2011-11-23       Impact factor: 4.778

3.  Directed Self-Assembly of Trimeric DNA-Bindingchiral Miniprotein Helicates.

Authors:  Jacobo Gómez-González; Diego G Peña; Ghofrane Barka; Giuseppe Sciortino; Jean-Didier Maréchal; Miguel Vázquez López; M Eugenio Vázquez
Journal:  Front Chem       Date:  2018-10-30       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.